Maintaining a Treatment Schedule
It’s important to make time for your prescribed CF treatment. If you have CF, you have to remain committed and plan ahead. If you don’t have CF, you can be supportive by understanding when a CF patient needs to break away from an activity for their prescribed treatment.
Understanding the science behind CF and treatments can be challenging. Check out the videos on the Pulmozyme web site to learn more about CF.
Pulmozyme may help to improve lung function and reduce the risk of respiratory tract infections.
Pulmozyme should not be used in patients who are allergic to any of its ingredients.
Pulmozyme should be used in conjunction with standard therapies for CF.
During Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and short-lived.
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.